165 related articles for article (PubMed ID: 12464151)
1. Mycophenolate mofetil and leflunomide: promising compounds for the treatment of skin diseases.
Frieling U; Luger TA
Clin Exp Dermatol; 2002 Oct; 27(7):562-70. PubMed ID: 12464151
[TBL] [Abstract][Full Text] [Related]
2. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
Geilen CC; Orfanos-Boeckel H; Offermann G; Orfanos CE
Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
[TBL] [Abstract][Full Text] [Related]
3. [Leflunomide--a new drug for pharmacological immunomodulation].
Wozel G; Pfeiffer C
Hautarzt; 2002 May; 53(5):309-15. PubMed ID: 12063741
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
Brazelton TR; Morris RE
Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398
[TBL] [Abstract][Full Text] [Related]
5. Triple drug treatment with cyclosporine, leflunomide and mycophenolate mofetil prevents rejection of pig islets transplanted into rats and primates.
Wennberg L; Groth CG; Tibell A; Zhu S; Liu J; Rafael E; Söderlund J; Biberfeld P; Morris RE; Karlsson-Parra A; Korsgren O
Transplant Proc; 1997 Aug; 29(5):2498. PubMed ID: 9270824
[No Abstract] [Full Text] [Related]
6. Tacrolimus enhances the immunosuppressive effect of cyclophosphamide but not that of leflunomide or mycophenolate mofetil in a model of discordant liver xenotransplantation.
Miki T; Goller A; Rao A; Wang X; Yin WY; Tandin A; Fung JJ; Starzl TE; Valdivia LA
Transplant Proc; 1998 Jun; 30(4):1091-2. PubMed ID: 9636444
[No Abstract] [Full Text] [Related]
7. Mycophenolic acid in dermatology a century after its discovery.
Strathie Page SJ; Tait CP
Australas J Dermatol; 2015 Feb; 56(1):77-83. PubMed ID: 25557632
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for the management of autoimmune bullous diseases.
Eskin-Schwartz M; David M; Mimouni D
Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the therapeutic effects of leflunomide and mycophenolate mofetil in the treatment of immunoglobulin A nephropathy manifesting with nephrotic syndrome.
Liu XW; Li DM; Xu GS; Sun SR
Int J Clin Pharmacol Ther; 2010 Aug; 48(8):509-13. PubMed ID: 20650041
[TBL] [Abstract][Full Text] [Related]
10. Diabetic rats transplanted with adult porcine islets and immunosuppressed with cyclosporine, mycophenolate mofetil, and leflunomide remain normoglycemic for up to 100 days.
Wennberg L; Song Z; Zhang J; Bennet W; Nava S; Bari S; Sundberg B; Korsgren O; Groth CG
Transplant Proc; 2000 Aug; 32(5):1061. PubMed ID: 10936353
[No Abstract] [Full Text] [Related]
11. Mycophenolate mofetil: a dermatologic perspective.
Mydlarski PR
Skin Therapy Lett; 2005 Apr; 10(3):1-6. PubMed ID: 15986076
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide in dermatology.
Boyd AS
J Am Acad Dermatol; 2012 Apr; 66(4):673-9. PubMed ID: 21962758
[TBL] [Abstract][Full Text] [Related]
13. [Other immunosuppressants: azathioprine (Imurel), mycophenolate mofetil (Cellcept), cyclophosphamide (Endoxan)].
Gaudy-Marqueste C
Ann Dermatol Venereol; 2007 Dec; 134(12):949-56. PubMed ID: 18166916
[No Abstract] [Full Text] [Related]
14. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
Nousari HC; Sragovich A; Kimyai-Asadi A; Orlinsky D; Anhalt GJ
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil: new applications for this immunosuppressant.
Moder KG
Ann Allergy Asthma Immunol; 2003 Jan; 90(1):15-19; quiz 20, 78. PubMed ID: 12546332
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression with cyclosporin A in combination with leflunomide and mycophenolate mofetil prevents rejection of pig-islets transplanted into rats.
Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
Transplant Proc; 1996 Apr; 28(2):819. PubMed ID: 8623416
[No Abstract] [Full Text] [Related]
17. New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications.
Assmann T; Ruzicka T
Clin Dermatol; 2002; 20(5):505-14. PubMed ID: 12435521
[No Abstract] [Full Text] [Related]
18. Mycophenolate mofetil in dermatology.
Orvis AK; Wesson SK; Breza TS; Church AA; Mitchell CL; Watkins SW
J Am Acad Dermatol; 2009 Feb; 60(2):183-99; quiz 200-2. PubMed ID: 19150270
[TBL] [Abstract][Full Text] [Related]
19. Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
Fragoso YD; Brooks JB
Expert Rev Clin Pharmacol; 2015 May; 8(3):315-20. PubMed ID: 25712857
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil.
Heymann WR
J Am Acad Dermatol; 2005 Dec; 53(6):1045-6. PubMed ID: 16310066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
